Company: DMAAR
Filing Date: 2025-01-22
Form Type: POS AM
Source: 0001213900-25-005176
Chunk: 0

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-22
Form: POS AM
Chunk 0
---
As filed with the U.S. Securities and Exchange Commission on January 21 , 2025. Registration No. 333-281170 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 __________________________________ POST-EFFECTIVE AMENDMENT NO. 2 TO
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933 __________________________________ Drugs Made In America Acquisition Corp. (Exact name of registrant as specified in its charter) __________________________________

| Cayman Islands                  |     |                         6770 |     | 99-2394788            |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -Primary Standard Industrial 
   Classification Code Number |     | -I.R.S. Employer      
 Identification Number |

Lynn Stockwell
Chief Executive Officer and Executive Chair
Drugs Made In America Acquisition Corp.
1 East Broward Boulevard, Suite 700
Fort Lauderdale, FL 33301
(954) 870 -3099 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
__________________________________ Copies to:

| Mitchell S. Nussbaum   
 G. Alex Weniger-Araujo 
 Loeb & Loeb LLP        
 345 Park Avenue        
 New York, NY 10154     
 Tel: (212) 407-4000    |     | Michael J. Blankenship         
 Winston & Strawn LLP           
 800 Capitol Street, Suite 2400 
 Houston, Texas 77002           
 Tel: (713) 651-2600            |

__________________________________ Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☐ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post -effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post -effective amendment filed pursuant to Rule